CITIC Securities: Overall strong innovation in Hong Kong-listed medical device companies, many companies are about to enter the stage of turning losses into profits or quickly releasing performance.

The CITIC Securities Research Report stated that Hong Kong-listed medical device companies have strong overall innovation, and several companies are about to enter a phase of turning losses into profits or rapid performance release. Since the beginning of this year, some 18A medical device companies with innovative products launched, breakthroughs in technology leading to license-out possibilities, rich cash reserves, rapid performance release, and low valuations have seen their share prices more than double; some leading medical device companies with high growth in performance and low valuations have also performed well since the beginning of the year. In the context of A-share medical device investment, CITIC Securities is optimistic about investment opportunities in companies that benefit from optimized medical device procurement policies, the launch of innovative products in high volume, and high growth in international business. It is expected that many companies will reach a turning point in performance in the second half of the year, with the third quarter expected to achieve high growth in performance.